ABSI Stock Analysis: Buy, Sell, or Hold?
ABSI - Absci Corporation Common Stock
$11.62
0.51 (4.59%)
β²
5d:
+13.81%
30d:
+82.99%
90d:
+268.89%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When ABSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR BETTER ENTRY: ABSI is 18.6% above its trading range ($9.80). While momentum could continue, risk/reward favors waiting for a pullback.
βΈοΈ WAIT FOR BETTER ENTRY: ABSI is 18.6% above its trading range ($9.80). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ABSI is currently trading at $11.62, which is considered extended relative to its 30-day fair value range of $5.78 to $9.80.
Technical Outlook: Technically, ABSI is in a strong uptrend. Immediate support is located at $7.11, while resistance sits at $12.05. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: ABSI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABSI is in a strong uptrend. Immediate support is located at $7.11, while resistance sits at $12.05. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: ABSI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.78 -
$9.80
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+18.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.6%)
- NEUTRAL: Near Wall St target ($12.40)
- WARNING: Recommendation downgraded due to 18.6% overvaluation
Trading Range Analysis
30-Day Trading Range
$5.78 -
$9.80
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.11
Resistance Level
$12.06
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.01
Wall Street Target
$12.40
(+6.7%)
Revenue Growth (YoY)
-81.8%
Share & Embed Analysis
Last updated: July 02, 2026 10:47 PM ET
Data refreshes hourly during market hours. Next update: 11:47 PM
Data refreshes hourly during market hours. Next update: 11:47 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABSI showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Andreas Busch
BUY
100000 shares
2026-03-12
Sean Mcclain
SELL
26761 shares
2026-02-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical β¦ |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1041 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 64 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |